Neuromod Raises $12.4 Million in Series B Funding for Lenire Tinnitus Treatment Device

The investment was led by majority investor Fountain Healthcare Partners, with participation from existing investors Moffett Investment Holdings and Medical Device Resources, with venture-debt provided by Kreos Capital and Silicon Valley Bank.